Current and Investigational Therapeutics for Fabry Disease

Fabry disease (FD) is an X-linked lysosomal storage disease caused by a deficiency in the lysosomal enzyme α-galactosidase (α-GAL). This in turn leads to the buildup of globotriaosylceramide, resulting classically in progressive kidney disease, peripheral neuropathy, early-onset cerebrovascular dise...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Kidney Int Rep
Main Authors: Felis, Andrew, Whitlow, Michael, Kraus, Abigayle, Warnock, David G., Wallace, Eric
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2019
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7136345/
https://ncbi.nlm.nih.gov/pubmed/32274449
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2019.11.013
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki